Company: MDCXW
Filing Date: 2025-05-27
Form Type: S-1
Source: 0001062993-25-010394
Chunk: 199

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-27
Form: S-1
Chunk 199
---
000 for fees and expenses of legal counsel and other out-of-pocket expenses out of the proceeds of the closing.

We or the placement agent may also ask other FINRA member broker-dealers that are registered with the SEC to participate as soliciting dealers for this offering. The placement agency agreement provides that the placement agent’s obligations are subject to conditions contained in the placement agency agreement.

We will deliver the securities being issued to the investors upon receipt of investor funds for the purchase of the securities offered pursuant to this prospectus. We expect to deliver the securities being offered pursuant to this prospectus on or about , 2025.

Indemnification

We have agreed to indemnify the placement agent against certain liabilities, including liabilities under the Securities Act and liabilities arising from breaches of representations and warranties contained in the placement agency agreement, or to contribute to payments that the placement agent may be required to make in respect of those liabilities.

<div align='center'>135</div>

Lock-Up Agreements

Each of our Directors and executive officers have agreed to a thirty (30) day “lock-up” period from the date of this prospectus with respect to the common shares that they beneficially own. This means that, for a period of thirty (30) days following the date of this prospectus, such persons may not offer, issuer, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any of our securities, subject to certain exceptions, without the prior written consent of the placement agent. We have also agreed, subject to certain exceptions (including with respect to the SEPA), to similar restrictions on the issuance, sale, disposal and registration of our securities for thirty (30) days following the date of this prospectus, without the prior written consent of the placement agent.

The placement agent has no present intention to waive or shorten the lock-up period; however, the terms of the lock-up agreements may be waived at its discretion. In determining whether to waive the terms of the lock-up agreements, the placement agent may base its decision on its assessment of the relative strengths of the securities markets and companies similar to ours in general, and the trading pattern of, and demand for, our securities in general.

Regulation M

The placement agent may be deemed to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and any commissions received by it and any profit realized on the resale of the securities sold by it while acting as principal might be deemed to be underwriting discounts